Use of ATR inhibitor in combination with topoisomerase I inhibitor kills cancer cells by disabling DNA replication initiation and fork elongation

被引：0
|
作者：
Josse, R. [1 ]
Martin, S. E. [2 ]
Guha, R. [2 ]
Ormanoglu, P. [2 ]
Pfister, T. [3 ]
Morris, J. [4 ]
Doroshow, J. [4 ]
Pommier, Y. [1 ]
机构：
[1] NCI, Dev Therapeut Branch, Bethesda, MD 20892 USA
[2] NCATS, Div Preclin Innovat, Rockville, MD USA
[3] Leidos Biomed Res Inc, Lab Human Toxicol & Pharmacol, Frederick, MD USA
[4] DTP DCTD, Drug Synth & Chem Branch, Bethesda, MD USA
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70374-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
248
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [41] Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models
    Wise, Hannah C.
    Iyer, Gopakumar V.
    Moore, Kathleen
    Temkin, Sarah M.
    Gordon, Sarah
    Aghajanian, Carol
    Grisham, Rachel N.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [42] Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models
    Hannah C. Wise
    Gopakumar V. Iyer
    Kathleen Moore
    Sarah M. Temkin
    Sarah Gordon
    Carol Aghajanian
    Rachel N. Grisham
    Scientific Reports, 9
  • [43] Synergistic activity of PI3K inhibitor in combination with AZD6738, ATR inhibitor in breast cancer preclinical model via DNA damage response pathway
    Moon, Yong Wha
    Gosh, Mithun
    Park, Nahee
    Pandey, Kamal
    Katwal, Nar Bahadur
    Hong, Sa Deok
    CANCER RESEARCH, 2023, 83 (05)
  • [44] Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells
    Toshihiko Sunami
    Kazuto Nishio
    Fumihiko Kanzawa
    Kazuya Fukuoka
    Shinzo Kudoh
    Jyunichi Yoshikawa
    Nagahiro Saijo
    Cancer Chemotherapy and Pharmacology, 1999, 43 : 394 - 401
  • [45] Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells
    Sunami, T
    Nishio, K
    Kanzawa, F
    Fukuoka, K
    Kudoh, S
    Yoshikawa, J
    Saijo, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (05) : 394 - 401
  • [46] Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex
    Sen, N.
    Banerjee, B.
    Das, B. B.
    Ganguly, A.
    Sen, T.
    Pramanik, S.
    Mukhopadhyay, S.
    Majumder, H. K.
    CELL DEATH AND DIFFERENTIATION, 2007, 14 (02): : 358 - 367
  • [47] A DNA TOPOISOMERASE-I INHIBITOR BLOCKS THE DIFFERENTIATION OF RAT GRANULOSA-CELLS INDUCED BY FOLLICLE-STIMULATING-HORMONE
    BARANAO, JL
    BLEY, MA
    BATISTA, FD
    GLIKIN, GC
    BIOCHEMICAL JOURNAL, 1991, 277 : 557 - 560
  • [48] Combination of a gamma secretase inhibitor with the Bcl-2 inhibitor ABT-737 kills Melanoma Cancer Initiating Cells (MICs) by inducing apoptosis and inhibits the self renewability of MICs
    Mukherjee, N.
    Almeida, A. R.
    Partyka, K. A.
    Schwan, J.
    Lu, Y.
    Luo, Y.
    Fujita, M.
    Shellman, Y. G.
    Norris, D. A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S125 - S125
  • [49] Mitochondrial Elongation and ROS-Mediated Apoptosis in Prostate Cancer Cells under Therapy with Apalutamide and Complex I Inhibitor
    Baumgartner, Valentin
    Schaer, Dominik
    Moch, Holger
    Salemi, Souzan
    Eberli, Daniel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [50] Combination of Gefitinib and DNA Methylation Inhibitor Decitabine Exerts Synergistic Anti-Cancer Activity in Colon Cancer Cells
    Lou, Yun-feng
    Zou, Zheng-zhi
    Chen, Pin-jia
    Huang, Guo-bin
    Li, Bin
    Zheng, De-qing
    Yu, Xiu-rong
    Luo, Xiao-yong
    PLOS ONE, 2014, 9 (05):
12345